1. Home
  2. ODTX vs LXU Comparison

ODTX vs LXU Comparison

Compare ODTX & LXU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Odyssey Therapeutics Inc. Common Stock

ODTX

Odyssey Therapeutics Inc. Common Stock

N/A

Current Price

$18.18

Market Cap

875.1M

Sector

Health Care

ML Signal

N/A

Logo LSB Industries Inc.

LXU

LSB Industries Inc.

HOLD

Current Price

$9.82

Market Cap

880.5M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODTX
LXU
Founded
N/A
1968
Country
United States
United States
Employees
N/A
513
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Major Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
875.1M
880.5M
IPO Year
2026
2006

Fundamental Metrics

Financial Performance
Metric
ODTX
LXU
Price
$18.18
$9.82
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$14.63
AVG Volume (30 Days)
246.6K
724.6K
Earning Date
N/A
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
225.93
EPS
N/A
0.18
Revenue
N/A
$615,208,000.00
Revenue This Year
N/A
$13.69
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$60.44
Revenue Growth
N/A
17.77
52 Week Low
$15.10
$7.15
52 Week High
$20.00
$17.22

Technical Indicators

Market Signals
Indicator
ODTX
LXU
Relative Strength Index (RSI) 53.31 32.72
Support Level $15.10 $9.25
Resistance Level $19.60 $15.56
Average True Range (ATR) 1.32 0.45
MACD 0.16 -0.07
Stochastic Oscillator 72.33 3.49

Price Performance

Historical Comparison
ODTX
LXU

About ODTX Odyssey Therapeutics Inc. Common Stock

Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.

About LXU LSB Industries Inc.

LSB Industries Inc is engaged in the manufacturing and sale of chemical products in the United States. The company manufactures and sells chemical products for the agricultural and industrial sectors. Its products include ammonia, fertilizer grade ammonium nitrate (AN and HDAN), and urea ammonia nitrate (UAN) for agricultural applications; high purity and commercial grade ammonia, sulfuric acids, concentrated, blended, and regular nitric acid, mixed nitrating acids, carbon dioxide, and diesel exhaust fluid for industrial applications; and industrial grade AN (LDAN) and AN solutions for mining applications. Its products are sold through distributors and directly to end customers throughout the United States and other parts of North America.

Share on Social Networks: